drugset / Trial / NCT00363844
Controlled Study of MK-0431/ONO-5435 in Patients With Type 2 Diabetes Mellitus
Non-randomizedSingle-groupOpen-labelTreatment
Summary
Determine the safety and efficacy of MK-0431/ONO-5435 in patients with Type 2 diabetes mellitus who have inadequate glycemic control on diet/exercise therapy
Timeline
- Start
- 2006-08
- Primary completion
- 2008-02
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sitagliptin | Small molecule | 50 mg | — |
| Subject | Sitagliptin | Small molecule | 100 mg | — |